<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Neuralgia]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/therapeutic-areas/central-nervous-system-cns/pain/neuropathic-pain/neuralgia</link>
    <description><![CDATA[Neuralgia]]></description>
    <pubDate>Thu, 16 Jul 2026 05:46:49 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/trigeminal-neuralgia-tic-douloureux-pipeline-review-h1-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H1 2019, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape.<br><br>Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Symptoms include spontaneous attacks of pain or attacks triggered by things such as touching the face, chewing, speaking and brushing teeth, pain in areas supplied by the trigeminal nerve, including the cheek, jaw, teeth, gums, lips, or less often the eye and forehead. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Trigeminal Neuralgia - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide cove...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208051"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Postherpetic Neuralgia- Market Insights, Epidemiology and Market Forecast-2023]]></title>
      <link>https://www.leadingmarketresearch.com/postherpetic-neuralgia-market-insights-epidemiology-and-market-forecast-2</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Note*: This report requires 7-10 business days to complete.

DelveInsight’s Postherpetic Neuralgia  - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Postherpetic Neuralgia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Postherpetic Neuralgia till 2023. 

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Postherpetic Neuralgia market. 
• Identifying patient populations in the global “Postherpetic Neuralgia market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Postherpetic Neuralgia  in each of the...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-195246"><span class="price">$4,950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 25 Apr 2017 20:08:12 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Trigeminal Neuralgia Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/trigeminal-neuralgia-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2016&quot; provides an overview of Trigeminal Neuralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Trigeminal Neuralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to g...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-184412"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Sep 2016 20:23:57 +0000</pubDate>
    </item>
  </channel>
</rss>
